Histological changes in the brain and liver of high-fat diet-fed male rats as a result of orlistat administration
DOI:
https://doi.org/10.60988/p.v37i2S.156Keywords:
histological changes; orlistat; rat; brain; liverAbstract
Obesity is a disorder characterized by excessive body weight gain. Orlistat is one of the medications used in the treatment of obesity, and acts by inhibiting gastric and pancreatic lipases. The objective of this study was to examine the short-term effects of orlistat on liver and brain tissues in rats fed a high-fat diet. In this study, 20 male albino rats (weighing approximately 193–212 g) were divided into two groups: group I (control group; consisting of five rats administered distilled water daily) and group II (orlistat group; comprising 15 rats given a daily oral dose of orlistat at a dose of 32 mg/kg body weight per day, via gastric tube, for 10 weeks). At the end of the experimental period, the animals were sacrificed, and the liver and brain tissues were prepared for histological analysis. Rats treated with orlistat exhibited degenerative changes in both liver and brain tissues compared to the control group. In the liver, these changes included dilation, blood vessel congestion, and lymphocyte infiltration. In the brain, the observed changes were characterized by the infiltration of neutrophils or mononuclear leukocytes. In conclusion, orlistat exerts harmful effects on liver and brain tissues; therefore, its clinical use should be closely monitored.
References
Townshend T., Lake A. Obesogenic environments: current evidence of the built and food environments. Perspect. Public Health 137(1), 38–44, 2017. DOI: 10.1177/1757913916679860
Borgström B. Mode of action of tetrahydrolipstatin: a derivative of the naturally occurring lipase inhibitor lipstatin. Biochim. Biophys. Acta 962(3), 308–316, 1988. DOI: 10.1016/0005-2760(88)90260-3
Wadden T.A., Webb V.L., Moran C.H., Bailer B.A. Lifestyle modification for obesity: new developments in diet, physical activity, and behavior therapy. Circulation 125(9), 1157–1170, 2012. DOI: 10.1161/CIRCULATIONAHA.111.039453
Tchang B.G., Aras M., Kumar R.B., Aronne L.J. Pharmacologic treatment of overweight and obesity in adults. In: Feingold K.R., Ahmed S.F., Anawalt B., Blackman M.R., Boyce A., Chrousos G., et al. (editors). Endotext [Internet]. South Dartmouth, MA: MDText.com, Inc., 2000.
Suvarna S.K., Layton C., Bancroft J.D. Bancroft’s Theory and Practice of Histological Techniques. Eighth Edition. London: Elsevier, 2019.
Atiq M., Davis J.C., Lamps L.W., Beland S.S., Rose J.E. Amiodarone induced liver cirrhosis. Report of two cases. J. Gastrointestin. Liver Dis. 18(2), 233–235, 2009.
Sahar Y. Light and electron microscopic study of the effect of orlistat on the liver of adult male albino rats and the possible protective role of β-carotene. Forensic Med. Anat. Res. 6(2), 20–36, 2018. DOI: 10.4236/fmar.2018.62003
Filippatos T.D., Derdemezis C.S., Gazi I.F., Nakou E.S., Mikhailidis D.P., Elisaf M.S. Orlistat-associated adverse effects and drug interactions: a critical review. Drug Saf. 31(1), 53–65, 2008. DOI: 10.2165/00002018-200831010-00005
Al-Safo A.A., Al-Duliami L.H. Histopathological study of orlistat and rosemary aqueous extract in the brain and liver of obese male rats. J. Appl. Vet. Sci. 7(2), 34–40, 2022. DOI: 10.21608/javs.2022.120677.1124
